Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

PennyStocks.com Announces Trade Alerts on: FARE, CLSP, TTNP, and AMBS

PennyStocks.com Announces Trade Alerts on: FARE, CLSP, TTNP, and AMBS
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=970659&ProfileId=051205&sourceType=1

NEW YORK, NY -- (Marketwire) -- 01/03/13 -- PennyStocks.com focuses on identifying the hottest small cap companies in today's market. We are the #1 source for the best penny stocks alerts.

Alerts for today are issued on the following stocks: FARE, CLSP, TTNP, and AMBS

World Moto, Inc. (OTCQB: FARE) - continued to trade in the green on Wednesday making it the third day in a row that the stock has closed with gains. The stock briefly touched its 52-week high of 19 cents and traded more than $3mil in volume.

You can read more about FARE here: http://pennystocks.com/reports/FARE

Callisto Pharmaceuticals, Inc. (OTCQB: CLSP) - hit a new 52-week high on Wednesday on trading volume well over 20x higher than usual. The Company focuses on the development of drugs to treat gastrointestinal (GI) disorders and diseases.

You can read more about CLSP here: http://pennystocks.com/reports/CLSP

Titan Pharmaceuticals Inc. (OTCQB: TTNP) - saw modest gains on a significant volume increase on Wednesday after the Company announced New Drug Application (NDA) for Probuphine has been accepted for review and granted Priority Review designation by the U.S. Food and Drug Administration. The stock closed in the green up over 12% on volume more than 6x higher than usual.

You can read more about TTNP here: http://pennystocks.com/reports/TTNP

Amarantus BioSciences, Inc. (OTCQB: AMBS) - hit an intra-day high of $0.195 on Wednesday. On December 3rd, shares were as low as $0.017 representing gains of over 1000% since then. Volume traded was over $3 million on Wednesday.

You can read more about AMBS here: http://pennystocks.com/reports/AMBS

For more promising small-cap companies that look poised for upside growth, visit:
http://www.pennystocks.com/r/news

This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Information, opinions and analysis contained herein are based on sources deemed to be reliable and are subject to change without notice. A third party has hired and paid one thousand two hundred and ninety five dollars for the publication and circulation of this news release. Accordingly, certain information included herein may be forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. No representation, expressed or implied, is made as to the accuracy, completeness or correctness. We accept no liability for any losses arising from an investor's reliance on or use of this report. We do not and have not had any ownership interest in said third party of any kind.

IO NewsWire
editor@ionewswire.com



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today